AAAAAA
Results:
1-14
|
Results: 14
Authors:
KELLY MG
CAZAUBON A
CORING E
DELLUOMO A
ECTOR L
GOLDSMITH B
GUASCH H
HURLIMANN J
JARLMAN A
KAWECKA B
KWANDRANS J
LAUGASTE R
LINDSTROM EA
LEITAO M
MARVAN P
PADISAK J
PIPP E
PRYGIEL J
ROTT E
SABATER S
VANDAM H
VIZINET J
Citation: Mg. Kelly et al., RECOMMENDATIONS FOR THE ROUTINE SAMPLING OF DIATOMS FOR WATER-QUALITYASSESSMENTS IN EUROPE, Journal of applied phycology, 10(2), 1998, pp. 215-224
Authors:
WEBERCHAPPUIS K
BIERIBURGER S
HURLIMANN J
Citation: K. Weberchappuis et al., COMPARISON OF PROGNOSTIC MARKERS DETECTED BY IMMUNOHISTOCHEMISTRY IN MALE AND FEMALE BREAST CARCINOMAS, European journal of cancer, 32A(10), 1996, pp. 1686-1692
Authors:
WAEBER G
HURLIMANN J
HAEFLIGER JA
GOMEZ F
NICOD P
GROUZMANN E
Citation: G. Waeber et al., NEUROPEPTIDE-Y SECRETION FROM A HUMAN INSULINOMA, Journal of endocrinological investigation, 19(3), 1996, pp. 190-195
Authors:
GUILLOU L
ESTREICHER A
CHAUBERT P
HURLIMANN J
KURT AM
METTHEZ G
IGGO R
GRAY AC
JICHLINSKI P
BENHATTAR J
Citation: L. Guillou et al., GERM-CELL TUMORS OF THE TESTIS OVEREXPRESS WILD-TYPE P53, The American journal of pathology, 149(4), 1996, pp. 1221-1228
Authors:
HURLIMANN J
LARRINAGA B
VALA DLM
Citation: J. Hurlimann et al., BCL-2 PROTEIN IN INVASIVE DUCTAL BREAST CARCINOMAS, Virchows Archiv, 426(2), 1995, pp. 163-168
Authors:
WAEBER G
HURLIMANN J
NICOD P
GROUZMANN E
Citation: G. Waeber et al., IMMUNOLOCALIZATION OF NEUROPEPTIDE-Y IN HUMAN PANCREATIC ENDOCRINE TUMORS, Peptides, 16(5), 1995, pp. 921-926
Authors:
HURLIMANN J
CHAUBERT P
BENHATTAR J
Citation: J. Hurlimann et al., P53 GENE ALTERATIONS AND P53 PROTEIN ACCUMULATION IN INFILTRATING DUCTAL BREAST CARCINOMAS - CORRELATION BETWEEN IMMUNOHISTOCHEMICAL AND MOLECULAR-BIOLOGY TECHNIQUES, Modern pathology, 7(4), 1994, pp. 423-428
Authors:
LOSI L
DIGREGORIO C
BRAUSI M
FANTE R
HURLIMANN J
Citation: L. Losi et al., EXPRESSION OF P53-PROTEIN IN PROSTATE CANCERS OF DIFFERENT HISTOLOGICTYPES, Pathology research and practice, 190(4), 1994, pp. 384-388
Authors:
BRAUNSCHWEIG R
HURLIMANN J
GLOOR E
CAMPICHE M
Citation: R. Braunschweig et al., IMMUNOHISTOCHEMICAL AND ULTRASTRUCTURAL F EATURES OF 8 OVARIAN CARCINOIDS, Annales de pathologie, 14(3), 1994, pp. 155-162
Authors:
HURLIMANN J
SARAGA EP
Citation: J. Hurlimann et Ep. Saraga, EXPRESSION OF P53 PROTEIN IN GASTRIC CARCINOMAS - ASSOCIATION WITH HISTOLOGIC TYPE AND PROGNOSIS, The American journal of surgical pathology, 18(12), 1994, pp. 1247-1253
Authors:
HURLIMANN J
Citation: J. Hurlimann, DESMIN AND NEURAL MARKER EXPRESSION IN MESOTHELIAL CELLS AND MESOTHELIOMAS, Human pathology, 25(8), 1994, pp. 753-757
Authors:
HURLIMANN J
SCHANZ F
Citation: J. Hurlimann et F. Schanz, THE EFFECTS OF ARTIFICIAL AMMONIUM ENHANCEMENT ON RIVERINE PERIPHYTICDIATOM COMMUNITIES, Aquatic sciences, 55(1), 1993, pp. 40-64
Authors:
HURLIMANN J
Citation: J. Hurlimann, PROGNOSTIC VALUE OF P53-PROTEIN EXPRESSION IN BREAST CARCINOMAS, Pathology research and practice, 189(9), 1993, pp. 996-1003
Authors:
HURLIMANN J
GEBHARD S
GOMEZ F
Citation: J. Hurlimann et al., ESTROGEN-RECEPTOR, PROGESTERONE-RECEPTOR, PS2, ERD5, HSP27 AND CATHEPSIN-D IN INVASIVE DUCTAL BREAST CARCINOMAS, Histopathology, 23(3), 1993, pp. 239-248
Risultati:
1-14
|